# Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subject

> **NCT03850834** · PHASE1 · UNKNOWN · sponsor: **CSPC ZhongQi Pharmaceutical Technology Co., Ltd.** · enrollment: 36 (estimated)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Ammoxetine Hydrochloride Enteric-coated Tablets
- **DRUG:** placebo enteric-coated tablets

## Key facts

- **NCT ID:** NCT03850834
- **Lead sponsor:** CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-10
- **Primary completion:** 2019-05-31
- **Final completion:** 2019-10-31
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2019-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03850834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03850834, "Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subject". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03850834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*